Marina Chiara Garassino

Papers

Total Citations

H-Index

About

Dr. Marina Chiara Garassino is a leading oncologist and researcher whose work has profoundly shaped the treatment of thoracic malignancies, particularly non-small cell lung cancer (NSCLC). Her key research areas include immunotherapy, targeted therapies, and the biology of rare thoracic tumors. Dr. Garassino is best known for her pivotal role in the SQUIRE trial, which established necitumumab as a first-line treatment for advanced squamous NSCLC, and for her leadership in the development of immunotherapy combinations that have improved survival outcomes for patients with lung cancer. Her research has been cited over 15,000 times, reflecting its transformative impact on clinical practice. Notably, she has spearheaded international collaborations, including the European Thoracic Oncology Platform (ETOP), and has authored landmark studies on the role of immune checkpoint inhibitors in both early and advanced-stage disease. Dr. Garassino’s work has been recognized with numerous awards, and she continues to drive innovation in precision oncology, making her a vital figure in the fight against lung cancer.